SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 59 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $99 | -99.8% | 23,300 | -52.6% | 0.00% | – |
| Q2 2022 | $49,000 | -94.8% | 49,118 | -60.8% | 0.00% | -100.0% |
| Q2 2021 | $936,000 | +132.3% | 125,452 | +82.8% | 0.00% | 0.0% |
| Q1 2021 | $403,000 | -66.1% | 68,612 | -72.9% | 0.00% | 0.0% |
| Q4 2020 | $1,190,000 | +14.0% | 253,212 | -16.5% | 0.00% | 0.0% |
| Q3 2020 | $1,044,000 | – | 303,412 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
| Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
| ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
| HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
| Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
| Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
| Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
| BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |